Skip to content

Family-centered HIV Care, Viral Suppression and Retention in HIV-positive Children, Swaziland

Effect of Family-centered Model of HIV Care (FAM-CARE) on Viral Suppression and Retention in Care of HIV-positive Children in Swaziland

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03397420
Acronym
FAM-CARE
Enrollment
742
Registered
2018-01-12
Start date
2017-09-13
Completion date
2019-07-30
Last updated
2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Brief summary

The study will evaluate the effect of implementing a family-centered care (FAM-CARE) program (where all HIV-positive family members are seen together as a unit and receive care together) on viral suppression and retention in HIV-positive children \<15 years through enrollment of a prospective cohort of 660 HIV-positive children and their caregivers at sites that were randomized to either implement the family-care program (intervention sites) or continue the current standard of care (control sites).

Detailed description

The proposed study will evaluate the effect of implementing a FAM-CARE program on viral suppression and retention in children through enrollment of a prospective cohort of HIV-positive children and their caregivers at sites implementing the FAM-CARE program and control sites continuing the current standard of care. The study will be conducted in four clusters of facilities (2 hospitals and 2 health centers and their filter clinics) in the Hhohho region of Swaziland. Two facility clusters (one hospital and one health center, with their filter clinics) will be randomized to initiate the FAM-CARE program with viral load monitoring and two clusters (one hospital and one health center, with their filter clinics) will be control standard-of care sites. A prospective cohort of HIV-positive children and their caregivers will be followed in the FAM-CARE program sites and control sites. Each child will be followed for 18 months following enrollment. The primary objective is to evaluate the effect of the FAM-CARE program on the rates of viral suppression and retention in care, comparing rates of viral suppression and retention in children enrolled in FAM-CARE versus control sites. The study will also evaluate factors associated with viral suppression and retention (including family demographic characteristics), and conduct qualitative interviews to assess the acceptability of the FAM-CARE program by caregivers and health care providers in the intervention sites.

Interventions

OTHERFAM-CARE

Family-centered care, where all HIV-positive family members are seen together as a unit and receive HIV care and treatment services together, for HIV-positive children and their caregivers

Sponsors

Elizabeth Glaser Pediatric AIDS Foundation
Lead SponsorOTHER
United States Agency for International Development (USAID)
CollaboratorFED
Ministry of Health, Swaziland
CollaboratorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 14 Years
Healthy volunteers
No

Inclusion criteria

* HIV-positive child aged \<15 years receiving HIV care at the study facility.

Exclusion criteria

* At least one family member residing in the household is also HIV-positive and is receiving services at the study facility

Design outcomes

Primary

MeasureTime frameDescription
Proportion of HIV-positive children on ART virally suppressed18 months after study enrollment.Proportion of HIV-positive children on ART with viral suppression (defined as HIV RNA copies/mL below the level of assay detection) and the proportion with HIV RNA \<1,000 copies/mL at 18 months after enrollment
Proportion of HIV-positive on ART virally unsuppressed18 months after study enrollment.Proportion of HIV-positive children on ART with HIV RNA \>1000 copies/mL 18 months after enrollment into the study.

Secondary

MeasureTime frameDescription
Proportion HIV-positive children on ART virally suppressed (<1,000 copies/mL of HIV RNA) at 6 and 12 months after study enrollment6 and 12 months after study enrollmentProportion of HIV-positive children on ART with viral suppression (defined as HIV RNA copies/mL below the level of assay detection) and HIV RNA \>1000 copies/mL
Loss to follow-up18 months after study enrollmentLoss to follow-up (not seen in clinical care \>3 months)
Acceptability of the FAM-CARE program based on individual interview responses18 months after study enrollmentAcceptability of the FAM-CARE program to caregivers and health care provider as measured from responses on individual interviews using a structured questionnaire
Factors associated with HIV viral suppression18 months after study enrollmentIndividual and family factors associated with viral suppression.
ART initiation18 months after study enrollmentART initiation in HIV-positive children not on ART at study entry

Countries

Eswatini

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026